>
AI model costs skyrocket, raising questions about access and control
U.S. DOE Announces $17.5B in Loans for 10 New Nuclear Reactors
Study reveals the power of SPICES in addressing metabolic issues
Senate GOP Farm Bill Draws Criticism From Advocates Over Environmental and Health Provisions
'Groundbreaking' Potential Lupus Cure Sends Patients into Remission, Allowing Dreams...
Speculations on What Could Show Physics Beyond the Standard Model
SpaceX Orbital Travel and Orbital Hotels Need Starfall – Getting Back Safe and Cheap is Exciting
Lizard-inspired wiggly wheels let Mars rover swim through sand
Fact Sheet: President Donald J. Trump Ushers in the Next Frontier of Quantum Innovation
Researchers at Johns Hopkins University just let an AI-guided robot remove a dead pig's gallblad
World's first consumer wing-in-ground effect aircraft takes flight
America's Military Readiness Depends On Deployable Nuclear Power
License Plate Cameras Are About To Start Tracking A Lot More Than Just Your Car
Heads up: Apparently the government is hiding cameras inside fake utility boxes

Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.